Literature DB >> 11092799

Complementary and alternative medicine in rheumatology.

E Ernst1.   

Abstract

Complementary and alternative medicine (CAM) has become an important subject for rheumatologists. This article is an attempt to provide an introduction to this subject. It will provide definitions of, and define the prevalence of, CAM. The emphasis of the article is on evaluating the efficacy of CAM treatment modalities. This is achieved by referring to systematic reviews of clinical trials of acupuncture for low back pain, osteo-arthritis, fibromyalgia, inflammatory rheumatoid disease and neck pain. Further areas addressed in this way are herbal remedies, fish oil and glucosamine. Moreover, massage therapy and spinal manipulation for back pain are discussed. The final sections of this review deal with the safety and cost of CAM. It is concluded that, in view of the popularity of CAM with rheumatological patients, rigorous research into CAM is the best way forward. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11092799     DOI: 10.1053/berh.2000.0110

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  12 in total

1.  Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy.

Authors:  Sarah K Nabukera; Paul A Romitti; Kimberly A Campbell; F John Meaney; Kristin M Caspers; Katherine D Mathews; Stacey M Hockett Sherlock; Soman Puzhankara; Christopher Cunniff; Charlotte M Druschel; Shree Pandya; Dennis J Matthews; Emma Ciafaloni
Journal:  J Child Neurol       Date:  2011-12-07       Impact factor: 1.987

2.  Association of complementary and alternative medicine use with symptoms and physical functional performance among adults with arthritis.

Authors:  Patricia A Sharpe; Sara Wilcox; Danielle E Schoffman; Brent Hutto; Andrew Ortaglia
Journal:  Disabil Health J       Date:  2015-06-27       Impact factor: 2.554

3.  Botanical Extracts from Rosehip (Rosa canina), Willow Bark (Salix alba), and Nettle Leaf (Urtica dioica) Suppress IL-1β-Induced NF-κB Activation in Canine Articular Chondrocytes.

Authors:  Mehdi Shakibaei; David Allaway; Simone Nebrich; Ali Mobasheri
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-14       Impact factor: 2.629

4.  Spiritual healing in the treatment of rheumatoid arthritis: an exploratory single centre, parallel-group, double-blind, three-arm, randomised, sham-controlled trial.

Authors:  Henning Bliddal; Robin Christensen; Lars Højgaard; Else Marie Bartels; Karen Ellegaard; Robert Zachariae; Bente Danneskiold-Samsøe
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-31       Impact factor: 2.629

5.  A comparison of Kneipp hydrotherapy with conventional physiotherapy in the treatment of osteoarthritis of the hip or knee: protocol of a prospective randomised controlled clinical trial.

Authors:  Martin Schencking; Adriane Otto; Tobias Deutsch; Hagen Sandholzer
Journal:  BMC Musculoskelet Disord       Date:  2009-08-19       Impact factor: 2.362

6.  Scleroderma, stress and CAM utilization.

Authors:  Ka-Kit Hui; Michael Francis Johnston; Marc Brodsky; Joe Tafur; Mai Kim Ho
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-25       Impact factor: 2.629

Review 7.  Intersection of inflammation and herbal medicine in the treatment of osteoarthritis.

Authors:  Ali Mobasheri
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

8.  Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial.

Authors:  Alain Jacquet; Pierre-Olivier Girodet; Antoine Pariente; Karelle Forest; Laurent Mallet; Nicholas Moore
Journal:  Arthritis Res Ther       Date:  2009-12-16       Impact factor: 5.156

9.  The use of CAM and conventional treatments among primary care consulters with chronic musculoskeletal pain.

Authors:  Majid Artus; Peter Croft; Martyn Lewis
Journal:  BMC Fam Pract       Date:  2007-05-04       Impact factor: 2.497

Review 10.  The future of osteoarthritis therapeutics: targeted pharmacological therapy.

Authors:  A Mobasheri
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.